Comments for PDLI - Stockpickr! Your Source for Stock Ideas

Comments for PDLI

Added By	Comments	Type	Date Added
barrons3	Highland Capital Management cut its position to 3,947,859 shares (3.3%) from (5.3%), after selling 2,393,566 from Aug. 8 to Sept. 16 at $10.26 to $12.50 each.	Love	September 27, 2008
barrons2	Hedge-fund Highland Capital Management reported that it had cut its position in the biotech company to 8.2 million shares (6.9%), from the 9.44 million (8.1%) reported on Dec. 18. 2007.	Love	August 02, 2008
kbarmansr	Own Shares	Love	April 28, 2008
High Dividends	forward P/E of 17 PEG of 0.91.	Love	February 07, 2008
barrons2	Hedge fund Highland Capital Management raised its position to 9.44 million shares (8.1%) from the 8.19 million (7%) it had reported owning on Dec. 12.	Love	December 22, 2007
barrons2	"Third Point liquidated its position by selling six million shares from Oct. 30 to Nov. 9 at $18.83 to $21.20 each."	Hate	November 17, 2007
memocobo	CNBC..............21.76................0.14...............10/16/07	Love	October 16, 2007
mjohncoady	Activist investing	Love	September 02, 2007
Retire Young	great spec play with massive cash flow	Love	August 07, 2007
jo ann putnam	spec. that is down	Hate	July 15, 2007
doyle	Thought it was undervalued $23.00 a share	Love	July 14, 2007
charrisusna	Remarkably quiet at PDL absent a few small SEC filings adjusting employee and board member compensation. Don't assume that Third Point has given up hope on ousting McDade just yet, as its near 10% stake in the company would take a little while to unwind and on the personal side a loss to McDade would be fairly embarrasing in my estimation.	Love	June 30, 2007
charrisusna	Very interested to see the outcome of the June 20 shareholder meeting. I hope sparks fly as Third Point comes in with guns blazing.	Love	June 19, 2007
ladyshark	Dan Loeb's Third Point Investors has upped its stake in pdli to 9.7%, has asked for 2 seats on the board and has said that the ceo shoud be fired if he doesn't voluntarily resign. The company is building out a new office in the bay area (for a $100 million build out cost) and, according to centient biotech investors, the only reason for the taj mahal that's being built is so the current ceo can be closer to home and closer to his boat slip. The new office results in a longer commute for most of the employees and there is concern about attrition because of that. PDL's revenue stream comes from humanizing monoclonal antiboldies for other biotechs.	Love	June 03, 2007
bearsltd	rumored takeover	Love	May 27, 2007
Gunners_revenge	P E bid will come	Love	May 10, 2007
Marandron	Bio Medical	Love	May 02, 2007
kanderson	spec	Love	April 28, 2007
scotteberle	speculative	Love	April 28, 2007
LJP1165	PIPELINE	Love	April 24, 2007
beatty05	Research	Love	April 23, 2007
hotstove	Some Pressure on managemant should have this co. making money	Love	April 21, 2007
Sandy44	Read on article on the stock about 10 months ago. Thought it was a good investment.	Love	April 20, 2007
koriometry	Activist shareholders, visibility.	Love	April 18, 2007
growthtogoodness	2nd x	Love	April 15, 2007
puregold24	defensive great potential	Love	April 06, 2007
Tausif Khan	Making royalties in millions of dollars from DNA	Love	April 01, 2007
growthtogoodness	6.37	Love	March 31, 2007
22bobbylayne	High potential reward.	Love	March 28, 2007
Madeleine	Thank you Mr. Loeb Thank you Mr. Loeb. Thank you Mr. Loeb.	Love	March 28, 2007